Hunan Fangsheng Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001VG6
CNY
9.46
-0.06 (-0.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Hunan Fangsheng Pharmaceutical Co., Ltd.

Why is Hunan Fangsheng Pharmaceutical Co., Ltd. ?

1
  • OPERATING CASH FLOW(Y) Highest at CNY 303.14 MM
  • DEBT-EQUITY RATIO (HY) Lowest at 22.07 %
  • RAW MATERIAL COST(Y) Fallen by -4.11% (YoY)
2
With ROE of 17.14%, it has a very attractive valuation with a 3.24 Price to Book Value
  • Over the past year, while the stock has generated a return of 25.03%, its profits have risen by 34.3% ; the PEG ratio of the company is 0.6
  • At the current price, the company has a high dividend yield of 3.7
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Hunan Fangsheng Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Hunan Fangsheng Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Hunan Fangsheng Pharmaceutical Co., Ltd.
-4.54%
0.20
33.26%
China Shanghai Composite
21.43%
1.58
14.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.80%
EBIT Growth (5y)
28.00%
EBIT to Interest (avg)
7.84
Debt to EBITDA (avg)
1.56
Net Debt to Equity (avg)
0.27
Sales to Capital Employed (avg)
0.75
Tax Ratio
11.54%
Dividend Payout Ratio
42.99%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.65%
ROE (avg)
12.21%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
2.37
EV to EBIT
13.19
EV to EBITDA
10.96
EV to Capital Employed
2.25
EV to Sales
2.38
PEG Ratio
0.83
Dividend Yield
6.74%
ROCE (Latest)
17.10%
ROE (Latest)
17.56%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 502.53 MM

DEBT-EQUITY RATIO (HY)

Lowest at 10.13 %

INTEREST COVERAGE RATIO(Q)

Highest at 4,369.18

RAW MATERIAL COST(Y)

Fallen by -11.76% (YoY

-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 1.4 times

Here's what is working for Hunan Fangsheng Pharmaceutical Co., Ltd.

Interest Coverage Ratio
Highest at 4,369.18
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Debt-Equity Ratio
Lowest at 10.13 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Operating Cash Flow
Highest at CNY 502.53 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Raw Material Cost
Fallen by -11.76% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hunan Fangsheng Pharmaceutical Co., Ltd.

Inventory Turnover Ratio
Lowest at 1.4 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio